Assembly Biosciences (ASMB) Receivables - Net (2017 - 2026)

Assembly Biosciences' Receivables - Net history runs 10 years deep, the most recent figure standing at $451000.0 for Q1 2026.

• In Q1 2026, Receivables - Net changed N/A year-over-year to $451000.0; the TTM figure through Mar 2026 stood at $451000.0 (changed N/A YoY), while the FY2025 annual figure was $974000.0, changed N/A from the prior year.
• Receivables - Net for Q1 2026 stood at $451000.0, down from $974000.0 in the prior quarter.
• The five-year high for Receivables - Net was $1.2 million in Q3 2022, with the low at $43000.0 in Q4 2023.
• The 5-year median for Receivables - Net is $524000.0 (2022), against an average of $610818.2.
• The sharpest annual moves came in 2022 and 2023: Receivables - Net soared 180.95% in 2022, then tumbled 95.44% in 2023.
• Assembly Biosciences' Receivables - Net stood at $944000.0 in 2022, then sank by 95.44% to $43000.0 in 2023, then changed by 0.0% to $43000.0 in 2024, then surged by 2165.12% to $974000.0 in 2025, then tumbled by 53.7% to $451000.0 in 2026.
• Business Quant data shows ASMB's Receivables - Net at $451000.0 in Q1 2026, $974000.0 in Q4 2025, and $912000.0 in Q3 2025.